Oklo shares surge 5.08% intraday after UBS raises price target to $95 from $65.

Oklo surged 5.08% intraday following UBS analyst Jon Windham’s upgrade of its price target to $95 from $65, citing the company’s potential to benefit from a generational nuclear build-out and its progress toward achieving criticality at its Idaho reactor by mid-2026. The move aligned with broader analyst optimism, including Cantor Fitzgerald’s $122 target, which highlighted Oklo’s small modular reactor technology and strategic partnerships, such as the Siemens Energy contract for its Aurora powerhouse. Despite UBS maintaining a “Neutral” rating and cautioning about Oklo’s high valuation (133x 2030 earnings estimates), the upgraded targets and project visibility spurred short-term buying. The stock’s intraday rally, however, reversed by midday, reflecting skepticism about Oklo’s pre-revenue status and regulatory risks, though the immediate catalyst remained the analyst-driven positive sentiment.